SERUM INSTITUTE
Live / Applied — Response to non-final action entered (as of 08 Sept 2026)
What this means for you
Not registered yet, but its 02 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79440218
- Mark type
- Stylized text
- Filed
- 02 Aug 2025
- Attorney of record
- Michele S. Katz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for use in the treatment of Haemorrhage from varices, ulcers, Metabolism, Carnitine deficiency, Cancer, Pain and inflammation, Nausea, Vomiting, Indigestion, Iron deficiency anaemia, Bleeding in gastrointestinal and urogenital systems, abdominal and pelvic area, Uterine bleeding, Infertility, Hyperprolactinaemic disorders, Endometriosis, Benign breast disease, Menorrhagia, Gynaecomastia, Secondary amenorrhoea, Endometriosis, Menstrual cycle, Preterm birth and recurrent miscarriage, Luteal phase defect, Natural or artificial menopause, Central precocious puberty, Diabetes; Contraceptive
Owner
Prosecution history
- 08 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Mar 2026 — REFUSAL PROCESSED BY IB
- 07 Mar 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 07 Mar 2026 — REFUSAL PROCESSED BY MPU
- 06 Feb 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 05 Feb 2026 — NON-FINAL ACTION WRITTEN
- 21 Jan 2026 — ASSIGNED TO EXAMINER
- 20 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 20 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Jan 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 25 Dec 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB